Kendricks, Ashunta R – Trademark Portfolio

Entity Type: 01

Kendricks, Ashunta R holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ASHUNTA SHERIFF BEAUTY. The owner is based in New york, NY.

100 Crosby Street suite 500

New york, NY 10012

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Kendricks, Ashunta R's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Kendricks, Ashunta R have?

Kendricks, Ashunta R has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Kendricks, Ashunta R file in?

Kendricks, Ashunta R files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Kendricks, Ashunta R's most well-known trademarks?

Kendricks, Ashunta R's registered trademark portfolio includes well-known marks such as ASHUNTA SHERIFF BEAUTY. These are among 1 currently registered trademark in the portfolio.

What is Kendricks, Ashunta R's trademark registration success rate?

Kendricks, Ashunta R has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.